The Canadian arm, A Germany based pharmaceutical multinational is all set to conduct IBM blockchain trials in Canada in order to increase the quality of clinical trials. Boehringer Ingelheim (Canada) announced on Tuesday that they have joined hands with IBM in order to ‘to improve trust, transparency, patient safety and patient empowerment in clinical trials’ using the tech giants blockchain platform.
According to the firm, the trial intends to address quality issues along with clinical trial processes and records which at press time are ‘often enormous or incomplete’ and has the potential to put patients at risk. The project will keep an update on how blockchain can help provide a framework which is decentralized in order to perpetuate the integrity of data while enabling the automation of processes resulting in boosting patient safety while bringing down the cost.
The vice president for medical and regulatory affairs at Boehringer Ingelheim, Dr. Uli Brodl in one of his statements said that ‘The clinical trial ecosystem is highly complex as it involves different stakeholders, resulting in limited trust, transparency and process inefficiencies without true patient empowerment.’ Following this, Claude Guay, IBM Canada’s general manager for services said that ‘We’ve been using blockchain in other industries, and we are now investigating how we can use this technology to give Canadian patients the same level of security and trust when it comes to their personal health information.’
Many other pharmaceutical firms have also been looking for options to attain benefits of integrating blockchain technology. It was in the month of January 2018, Sanofi, Amgen, and Pfizer were looking at blockchain technology as a funnel to streamline the process of developing and testing new drugs.
Previously in the month of June, Merck was looking for a patient in order to use blockchain for tracking goods while they move through the supply chain system along with the concern of counterfeit meds. According to the Indian Government, Niti Aayog was in the process of working on a blockchain solution which is intended to fight the country’s roaring counterfeit drugs.